Regeneron Pharmaceuticals, Inc. and Sanofi announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA)...
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application...
Bristol Myers Squibb announced results from the Phase 3 VALOR-HCM study, which showed the addition of mavacamten, an investigational, first-in-class cardiac myosin inhibitor, significantly...
Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced that ONTOZRY® (cenobamate) is now available in the Netherlands for...
Global technology firm Digital Intelligence Systems, LLC (DISYS) announced a partnership with ComplianceQuest, the leading provider of 100% cloud-native, AI-powered, Enterprise Clinical, Quality Health,...
